Thyroid Eye Disease/ Graves' Ophthalmopathy - new treatment being studied
Teprotumumab is a new monoclonal antibody against the IGF-I receptor that has shown promise at reducing proptosis in moderate to sever Grave
Graves Hyperthyroidism - information for patients
Dr Philip Kelly, consultant endocrinologist at King's College Hospital discusses Graves' thyrotoxicosis, what is it, how does it pre
Thyroid Eye Disease and Smoking
Graves' thyrotoxicosis is the commonest cause of hyperthyroidism; thyroid eye disease is common in Graves', though mostly it is mild
